Literature DB >> 16356431

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia.

Shailender Mehta1, Praveen Kumar, Anil Narang.   

Abstract

OBJECTIVE: To evaluate the effectiveness of fluid supplementation in decreasing the rate of exchange transfusion and the duration of phototherapy in term neonates with severe nonhemolytic hyperbilirubinemia. STUDY
DESIGN: This was a randomized controlled trial conducted in a tertiary care referral unit in northern India. Seventy-four term neonates with severe nonhemolytic hyperbilirubinemia (total serum bilirubin > 18 mg/dL [308 micromol/L] to < 25 mg/dL [427 micromol/L]). The subjects were randomized to an "extra fluids" group (intravenous fluid supplementation for 8 hours and oral supplementation for the duration of phototherapy; n = 37) or a control group (n = 37).
RESULTS: At inclusion, 54 infants (73%) had high serum osmolality, including 28 (75%) in the extra fluids group and 26 (70%) in the control group. The proportion of infants who underwent exchange transfusion was lower in the extra fluids group than in the control group: 6 (16%) versus 20 (54%)(P = .001; relative risk = 0.30; 95% confidence interval = 0.14 to 0.66). The duration of phototherapy was also shorter in the extra fluids group: 52 +/- 18 hours versus 73 +/- 31 hours (P = .004).
CONCLUSION: Fluid supplementation in term neonates presenting with severe hyperbilirubinemia decreased the rate of exchange transfusion and duration of phototherapy.

Entities:  

Mesh:

Year:  2005        PMID: 16356431     DOI: 10.1016/j.jpeds.2005.07.026

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.

Authors:  Michael W Kuzniewicz; Gabriel J Escobar; Soora Wi; Petra Liljestrand; Charles McCulloch; Thomas B Newman
Journal:  J Pediatr       Date:  2008-03-21       Impact factor: 4.406

Review 2.  The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Authors:  Tao Xiong; Yi Qu; Stephanie Cambier; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-04-01       Impact factor: 3.183

Review 3.  Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings.

Authors:  Cecilia A Mabogunje; Sarah M Olaifa; Bolajoko O Olusanya
Journal:  World J Clin Pediatr       Date:  2016-05-08

4.  Fluid supplementation in hyperbilirubinemia.

Authors:  Shiv Sajan Saini; Praveen Kumar; Karthik Balasubramanium; Shailender Mehta
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

5.  Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

Review 6.  Fluid supplementation for neonatal unconjugated hyperbilirubinaemia.

Authors:  Nai Ming Lai; Azanna Ahmad Kamar; Yao Mun Choo; Juin Yee Kong; Chin Fang Ngim
Journal:  Cochrane Database Syst Rev       Date:  2017-08-01

Review 7.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

8.  Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia.

Authors:  Ariel A Salas; Jorge Salazar; Claudia V Burgoa; Carlos A De-Villegas; Valeria Quevedo; Amed Soliz
Journal:  BMC Pediatr       Date:  2009-12-31       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.